UC Irvine research team identifies glycosylation enzyme critical in brain formation

(Press-News.org) Irvine, Calif., May 16, 2023 — The MGAT5 glycosylation enzyme plays a crucial role in brain development, according to a study by University of California, Irvine researchers, a discovery that may contribute to new therapeutic purposes for neural stem cells.

Neurons, astrocytes and oligodendrocytes are the final mature cells of the brain and spinal cord formed by neural stem cells. Each has distinct and key functions. Neurons transmit signals, astrocytes help modify those signals, and oligodendrocytes keep the signals from degrading. When any cells make proteins or fats that end up on the cell surface, they often add small sugar molecules. The team tested whether this internal process – called glycosylation – affects how neural stem cells form mature brain cells.

The study, published in the journal Stem Cell Reports, found that during glycosylation, the MGAT5 enzyme significantly regulates the formation of neurons and astrocytes from neural stem cells. Neural stem cells that don’t have MGAT5 make more neurons and fewer astrocytes during the very early stages of brain development, altering its structure. These changes may contribute to later aberrant behavior patterns, including abnormal social interactions and repetitive actions.

“Now that we know MGAT5 and glycosylation have a substantial impact on neuron and astrocyte formation, we have a better idea of how our nervous system develops,” said corresponding author Lisa Flanagan, professor of neurology in UCI’s School of Medicine. “We hope these findings will contribute to the use of neural stem cells for therapeutic purposes by providing new information about the factors regulating these cells.”

It was known that neural stem cells respond to the external signals they encounter during development. But it was not known whether neural stem cells could modify their responses to those signals. The team analyzed the role of glycosylation enzymes in brain maturation by comparing control mice to those whose neural stem cells did not have the MGAT5 enzyme. It found that neural stem cells use glycosylation to manage their reactions to external signals and regulate the development of mature brain cells.

“As we continue our work, we hope to determine which cell surface proteins and pathways controlled by glycosylation are critical for neuron and astrocyte formation,” Flanagan said. “This will give us better insight into the external signals significantly modified by neural stem cell glycosylation, which will, in turn, help to decode the complex processes that occur during brain development and expand the therapeutic usefulness of neural stem cells.”

The team included researchers from the School of Medicine’s departments of anatomy & neurobiology, neurology, and pathology & laboratory medicine as well as The Henry Samueli School of Engineering’s Department of Biomedical Engineering and the Sue & Bill Gross Stem Cell Research Center.

This work was supported by the National Science Foundation under awards IOS-2019400 and IOS-1254060; by the National Institutes of Health under award T32 NS082174; and by a Brython Davis Fellowship.

About the University of California, Irvine: Founded in 1965, UCI is a member of the prestigious Association of American Universities and is ranked among the nation’s top 10 public universities by U.S. News & World Report. The campus has produced five Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 36,000 students and offers 224 degree programs. It’s located in one of the world’s safest and most economically vibrant communities and is Orange County’s second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide. For more on UCI, visit www.uci.edu.

Media access: Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UCI faculty and experts, subject to availability and university approval. For more UCI news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.

END